CMTM Antibodies

Santa Cruz Biotechnology features a diverse variety of CMTM Antibodies for advanced research in cell signaling and cancer biology. CMTM Antibodies are compatible with multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CKLF-like MARVEL transmembrane domain-containing (CMTM) proteins regulate cell proliferation, migration, and apoptosis. CMTM expression patterns influence various cellular processes, making them significant in understanding tumorigenesis and potential therapeutic targets in cancer treatment. Research focused on CMTM proteins continues to reveal new insights into disease progression mechanisms. Understanding CMTM protein function aids in developing novel diagnostic and therapeutic strategies. Investigating CMTM protein interactions helps identify new pathways in cancer development and progression. The extensive selection of monoclonal CMTM antibodies from Santa Cruz Biotechnology enables researchers worldwide to advance scientific understanding of cellular processes and disease mechanisms.